| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.075 | 5.317 | 16.769 | 418 | 45.504 | 52.515 | 44.069 | 54.878 |
| Total Income - EUR | - | - | 4.075 | 5.317 | 16.810 | 577 | 45.623 | 52.616 | 44.070 | 54.908 |
| Total Expenses - EUR | - | - | 2.195 | 6.120 | 2.890 | 6.688 | 9.455 | 25.747 | 42.871 | 27.669 |
| Gross Profit/Loss - EUR | - | - | 1.880 | -803 | 13.920 | -6.112 | 36.168 | 26.870 | 1.199 | 27.239 |
| Net Profit/Loss - EUR | - | - | 1.757 | -963 | 13.502 | -6.127 | 34.801 | 25.294 | 759 | 23.492 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cyteka Laboratories Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 1.381 | 1.325 | 22.873 | 22.448 | 23.695 |
| Current Assets | - | - | 1.973 | 2.224 | 16.121 | 6.049 | 35.845 | 43.296 | 27.959 | 68.193 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 6.871 | 0 | 3.002 | 499 | 1.461 | 750 |
| Cash | - | - | 1.973 | 2.224 | 9.249 | 6.049 | 32.844 | 42.796 | 26.498 | 67.442 |
| Shareholders Funds | - | - | 1.823 | 827 | 14.313 | 7.915 | 42.541 | 67.967 | 68.519 | 91.628 |
| Social Capital | - | - | 66 | 64 | 63 | 62 | 61 | 61 | 202 | 201 |
| Debts | - | - | 150 | 1.397 | 1.808 | 1.421 | 1.323 | 1.614 | 374 | 2.720 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6392 - 6392" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Cyteka Laboratories Srl